Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

Abstract Triple‐negative breast cancer (TNBC) often develops resistance to single‐agent treatment, which can be circumvented using targeted combinatorial approaches. Here, we demonstrate that the simultaneous inhibition of LOXL2 and BRD4 synergistically limits TNBC proliferation in vitro and in vivo...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Laura Pascual‐Reguant, Queralt Serra‐Camprubí, Debayan Datta, Damiano Cianferoni, Savvas Kourtis, Antoni Gañez‐Zapater, Chiara Cannatá, Lorena Espinar, Jessica Querol, Laura García‐López, Sara Musa‐Afaneh, Maria Guirola, Anestis Gkanogiannis, Andrea Miró Canturri, Marta Guzman, Olga Rodríguez, Andrea Herencia‐Ropero, Joaquin Arribas, Violeta Serra, Luis Serrano, Tian V Tian, Sandra Peiró, Sara Sdelci
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Springer Nature 2023-11-01
Serie:	EMBO Molecular Medicine
Ämnen:	cell cycle combinatorial therapy gene expression triple‐negative breast cancer
Länkar:	https://doi.org/10.15252/emmm.202318459
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!